Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSB1900033	精蛋白锌重组人胰岛素注射液（预混50R）		Injection	Biological Products	Supplementary Application	2019-01-23	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2020-02-17	view
JYSB1900034	精蛋白锌重组人胰岛素注射液（预混50R）		Injection	Biological Products	Supplementary Application	2019-01-18	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2020-02-17	view
CYSB1900008	精蛋白锌重组人胰岛素注射液（预混50R）		Injection	Biological Products	Supplementary Application	2019-01-22	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd	Certificate Issued	2019-12-11	view
CYSB1900007	精蛋白锌重组人胰岛素注射液（预混30R）		Injection	Biological Products	Supplementary Application	2019-01-22	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd	Certificate Issued	2019-12-11	view
JYSB1900017	精蛋白锌重组人胰岛素注射液（预混30R）		Injection	Biological Products	Supplementary Application	2019-01-23	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2020-02-17	view
JYSB1900024	精蛋白锌重组人胰岛素注射液（预混30R）		Injection	Biological Products	Supplementary Application	2019-01-23	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2020-02-17	view
JYSB1900019	精蛋白锌重组人胰岛素注射液（预混30R）		Injection	Biological Products	Supplementary Application	2019-01-17	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2020-02-17	view
JYSB1900009	精蛋白锌重组人胰岛素注射液（预混30R）		Injection	Biological Products	Supplementary Application	2019-01-23	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2020-02-17	view
JYSB1900015	精蛋白锌重组人胰岛素注射液（预混30R）		Injection	Biological Products	Supplementary Application	2019-01-17	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2020-02-17	view
JYSB1900013	精蛋白锌重组人胰岛素注射液（预混30R）		Injection	Biological Products	Supplementary Application	2019-01-23	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2020-02-17	view
JYSB1900025	精蛋白锌重组人胰岛素注射液（预混30R）		Injection	Biological Products	Supplementary Application	2019-01-17	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2020-02-17	view
JYSB1900021	精蛋白锌重组人胰岛素注射液（预混30R）		Injection	Biological Products	Supplementary Application	2019-01-23	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2020-02-17	view
JYSB1900023	精蛋白锌重组人胰岛素注射液（预混30R）		Injection	Biological Products	Supplementary Application	2019-01-17	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2020-02-17	view
JYSB1500179	精蛋白锌重组人胰岛素注射液	Protamine Zinc Recombinant Human Insulin	Injection	Biological Products	Supplementary Application	2015-07-03	Lilly France	Lilly France	Certificate Issued	2016-09-07	view
JYSB1900022	精蛋白锌重组人胰岛素注射液	Protamine Zinc Recombinant Human Insulin	Injection	Biological Products	Supplementary Application	2019-01-17	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2020-03-03	view
JYSB1000071	精蛋白锌重组人胰岛素注射液	Protamine Zinc Recombinant Human Insulin	Injection	Biological Products	Supplementary Application	2010-04-15	Lilly France	Lilly France	Certificate Issued	2010-09-09	view
JYSB2000263	精蛋白锌重组人胰岛素注射液	Protamine Zinc Recombinant Human Insulin	Injection	Biological Products	Supplementary Application	2020-06-18	Lilly France	Lilly France	Filed	2020-06-22	view
JYSB1300133	精蛋白锌重组人胰岛素注射液	Protamine Zinc Recombinant Human Insulin	Injection	Biological Products	Supplementary Application	2013-06-03	Lilly France	Lilly France	Certificate Issued	2015-01-08	view
JYSB1700088	精蛋白锌重组人胰岛素注射液	Protamine Zinc Recombinant Human Insulin	Injection	Biological Products	Supplementary Application	2017-05-03	Lilly France	Lilly France	In Review	2017-04-29	view
JYSB0700106	精蛋白锌重组人胰岛素注射液	Protamine Zinc Recombinant Human Insulin	Injection	Biological Products	Supplementary Application	2007-07-18	Lilly Egypt	Lilly Egypt	Certificate Issued	2008-02-15	view